{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:52:36Z","timestamp":1780685556555,"version":"3.54.1"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Emerging cancers are sculpted by neo-Darwinian selection for superior growth and survival but minimal immunogenicity; consequently, metastatic cancers often evolve common genetic and epigenetic signatures to elude immune surveillance. Immune subversion by metastatic tumours can be achieved through several mechanisms; one of the most frequently observed involves the loss of expression or mutation of genes composing the MHC-I antigen presentation machinery (APM) that yields tumours invisible to Cytotoxic T lymphocytes, the key component of the adaptive cellular immune response. Fascinating ethnographic and experimental findings indicate that cannabinoids inhibit the growth and progression of several categories of cancer; however, the mechanisms underlying these observations remain clouded in uncertainty. Here, we screened a library of cannabinoid compounds and found molecular selectivity amongst specific cannabinoids, where related molecules such as \u03949-tetrahydrocannabinol, cannabidiol, and cannabigerol can reverse the metastatic immune escape phenotype <jats:italic>in vitro<\/jats:italic> by inducing MHC-I cell surface expression in a wide variety of metastatic tumours that subsequently sensitizing tumours to T lymphocyte recognition. Remarkably, H3K27Ac ChIPseq analysis established that cannabigerol and gamma interferon induce overlapping epigenetic signatures and key gene pathways in metastatic tumours related to cellular senescence, as well as APM genes involved in revealing metastatic tumours to the adaptive immune response. Overall, the data suggest that specific cannabinoids may have utility in cancer immunotherapy regimens by overcoming immune escape and augmenting cancer immune surveillance in metastatic disease. Finally, the fundamental discovery of the ability of cannabinoids to alter epigenetic programs may help elucidate many of the pleiotropic medicinal effects of cannabinoids on human physiology.<\/jats:p>","DOI":"10.3389\/fimmu.2022.982082","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T08:52:53Z","timestamp":1677055973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours"],"prefix":"10.3389","volume":"13","author":[{"given":"Sarah","family":"Dada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L. S.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian L.","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas H.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Saranchova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonna","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl G.","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Eyford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Kari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Garrovillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Caspani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Al Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunc","family":"Morova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Tjoelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred A.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/75373","article-title":"TAP expression provides a general method for improving the recognition of malignant cells in vivo","volume":"18","author":"Alimonti","year":"2000","journal-title":"Nat Biotechnol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discovery."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/355644a0","article-title":"Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer","volume":"355","author":"Spies","year":"1992","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.1703","article-title":"A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum","volume":"166","author":"Diedrich","year":"2001","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0198-8859(00)00097-5","article-title":"High frequency of altered HLA class I phenotypes in laryngeal carcinomas","volume":"61","author":"Cabrera","year":"2000","journal-title":"Hum Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/scbi.2001.0404","article-title":"HLA class I antigen abnormalities and immune escape by malignant cells","volume":"12","author":"Seliger","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.4.280","article-title":"Molecular characterization of defective antigen processing in human prostate cancer","volume":"87","author":"Sanda","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"B8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1126\/science.3975631","article-title":"Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene","volume":"228","author":"Tanaka","year":"1985","journal-title":"Science."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950060503","article-title":"Diversification and progression of malignant tumors","volume":"6","author":"Nicolson","year":"1987","journal-title":"Bioessays."},{"key":"B10","article-title":"Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line","volume":"56","author":"Alpan","year":"1996","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000071272","article-title":"Tumor antigens and antigen-presenting capacity in breast cancer","volume":"70","author":"McDermott","year":"2002","journal-title":"Pathobiology."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270207","article-title":"CD45-associated protein is a lymphocyte-specific membrane protein expressed in two distinct forms","volume":"27","author":"Kitamura","year":"1997","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4","article-title":"TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis","volume":"95","author":"Kamarashev","year":"2001","journal-title":"Int J Cancer."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511525200","article-title":"Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells","volume":"281","author":"Chang","year":"2006","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20526","article-title":"Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors","volume":"113","author":"Cabrera","year":"2005","journal-title":"Int J Cancer."},{"key":"B16","article-title":"MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer","volume":"23","author":"Andratschke","year":"2003","journal-title":"Anticancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00262-007-0362-8","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma","volume":"57","author":"Mehta","year":"2008","journal-title":"Cancer Immunol Immunother."},{"key":"B18","first-page":"2","article-title":"Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer","volume":"3","author":"Zhang","year":"2003","journal-title":"Cancer Immun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80301-X","article-title":"Loss of HLA class I expression in prostate cancer: implications for immunotherapy","volume":"46","author":"Blades","year":"1995","journal-title":"Urology."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2002.02993.x","article-title":"Correlation between major histocompatibility complex class I molecules and CD8+ T lymphocytes in prostate, and quantification of CD8 and interferon-gamma mRNA in prostate tissue specimens","volume":"90","author":"Naoe","year":"2002","journal-title":"BJU Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.183.4124.534","article-title":"Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice","volume":"183","author":"Stutman","year":"1974","journal-title":"Science."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1066","article-title":"Combining the antigen processing components TAP and tapasin elicits enhanced tumor-free survival","volume":"14","author":"Lou","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1415","article-title":"Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing","volume":"180","author":"Gabathuler","year":"1994","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.064","article-title":"Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1","volume":"25","author":"Lou","year":"2007","journal-title":"Vaccine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.gene.6364035","article-title":"Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1","volume":"5","author":"Brucet","year":"2004","journal-title":"Genes Immun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22371","article-title":"TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma","author":"Zhang","year":"2007","journal-title":"Int J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3977","article-title":"Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival","volume":"65","author":"Lou","year":"2005","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01547-07","article-title":"Epigenetic control of the immune escape mechanisms in malignant carcinomas","volume":"27","author":"Setiadi","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5270","article-title":"Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.","volume":"68","author":"Setiadi","year":"2008","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41598-018-20608-6","article-title":"Type 2 innate lymphocytes actuate immunity against tumours and limit cancer metastasis","volume":"8","author":"Saranchova","year":"2018","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30555","DOI":"10.1038\/srep30555","article-title":"Discovery of a metastatic immune escape mechanism initiated by the loss of expression of the tumour biomarker interleukin-33","volume":"6","author":"Saranchova","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0402","article-title":"The combination of cannabidiol and Delta9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model","volume":"13","author":"Scott","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00720","article-title":"Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms","volume":"8","author":"Soderstrom","year":"2017","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1016\/S0264-410X(02)00519-4","article-title":"Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules","volume":"21","author":"Smahel","year":"2003","journal-title":"Vaccine"},{"key":"B36","article-title":"Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein","volume":"27","author":"Smahel","year":"2005","journal-title":"Int J Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.26.2.521","article-title":"Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy","volume":"26","author":"Mikyskova","year":"2005","journal-title":"Int J Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.101","article-title":"Identifying ChIP-seq enrichment using MACS","volume":"7","author":"Feng","year":"2012","journal-title":"Nat Protoc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/496521","article-title":"Improved peak-calling with MACS2","author":"Gaspar","year":"2018","journal-title":"bioRxiv"},{"key":"B40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12859-017-1708-7","article-title":"Intervene: a tool for intersection and visualization of multiple gene or genomic region sets","volume":"18","author":"Khan","year":"2017","journal-title":"BMC Bioinf"},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2015.12.007","article-title":"The urgent need to recover MHC class I in cancers for effective immunotherapy","volume":"39","author":"Garrido","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5270","article-title":"Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors","volume":"68","author":"Setiadi","year":"2008","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3734","article-title":"Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas","volume":"65","author":"Setiadi","year":"2005","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29375","article-title":"Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype","volume":"138","author":"Garrido","year":"2016","journal-title":"Int J Cancer."},{"key":"B45","article-title":"Induction of the antigen presentation machinery using novel small molecules [Text]","author":"Ellis","year":"2017"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.6.2974","article-title":"IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides","volume":"151","author":"Jefferies","year":"1993","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.304956","article-title":"The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes","volume":"286","author":"Bartoszewski","year":"2011","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MAJ.0000000000000466","article-title":"Synthetic cannabinoids","volume":"350","author":"Mills","year":"2015","journal-title":"Am J Med Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.08.002","article-title":"Therapeutic use of synthetic cannabinoids: Still an OpenIssue","volume":"40","author":"De Luca","year":"2018","journal-title":"Clin Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45862","article-title":"Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice","volume":"121","author":"Lu","year":"2011","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1073\/pnas.1506357112","article-title":"Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb","volume":"112","author":"Weigelin","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061890","article-title":"In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor","volume":"204","author":"Boissonnas","year":"2007","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1038\/s41467-021-25282-3","article-title":"Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity","volume":"12","author":"Weigelin","year":"2021","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2220\/biomedres.32.159","article-title":"One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry","volume":"32","author":"Nakagawa","year":"2011","journal-title":"BioMed Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401528101","article-title":"Inhibition of primary human T cell proliferation by helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion","volume":"101","author":"Sundrud","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3897","article-title":"MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction","volume":"6","author":"Banik","year":"2015","journal-title":"Oncotarget."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020457","article-title":"Role of angiopoietins in development of cancer and neoplasia associated with viral infection","volume":"9","author":"Yu","year":"2020","journal-title":"Cells."},{"key":"B58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.prnil.2016.02.003","article-title":"Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins","volume":"4","author":"Furuya","year":"2016","journal-title":"Prostate Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-26573-2_25","article-title":"Human studies of cannabinoids and medicinal cannabis","author":"Robson","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2016.1145794","article-title":"Cannabinoids: Medical implications","volume":"48","author":"Schrot","year":"2016","journal-title":"Ann Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1152\/physrev.00025.2001","article-title":"The transporter associated with antigen processing: function and implications in human diseases","volume":"82","author":"Lankat-Buttgereit","year":"2002","journal-title":"Physiol Rev"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.6.2974","article-title":"IFN-gamma-induced recognition of the antigen-processing variant CMT. 64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides","volume":"151","author":"Jefferies","year":"1993","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.52.220","article-title":"HLA class I defects in malignant lesions: what have we learned","volume":"52","author":"Chang","year":"2003","journal-title":"Keio J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706848200","article-title":"Activation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700233","article-title":"Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain","volume":"85","author":"Zagzag","year":"2005","journal-title":"Lab Invest."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/immu.200310016","article-title":"The ABC-transporter signature motif is required for peptide translocation but not peptide binding by TAP","volume":"33","author":"Hewitt","year":"2003","journal-title":"Eur J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB1, non-CB2 cannabinoid related G-Protein-Coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2017_1520","article-title":"Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma colo-205 cell line: an in vitro study","volume":"64","author":"Wasilewski","year":"2017","journal-title":"Acta Biochim Pol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.10.432967","article-title":"Cannabidiol inhibits SARS-CoV-2 replication and promotes the host innate immune response","author":"Nguyen","year":"2021","journal-title":"bioRxiv."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Delta9-tetrahydrocannabinol in BV-2 microglial cells","volume":"165","author":"Juknat","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/life10100227","article-title":"The transcriptomic analysis of NSC-34 motor neuron-like cells reveals that cannabigerol influences synaptic pathways: A comparative study with cannabidiol","volume":"10","author":"Gugliandolo","year":"2020","journal-title":"Life (Basel)."},{"key":"B74","doi-asserted-by":"publisher","first-page":"20622","DOI":"10.1038\/s41598-020-77674-y","article-title":"Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma","volume":"10","author":"Go","year":"2020","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.1c00946","article-title":"Cannabinoids block cellular entry of SARS-CoV-2 and the emerging variants","author":"van Breemen","year":"2022","journal-title":"J Natural Products"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacol (Berl)."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0578-5","article-title":"Randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"B80","doi-asserted-by":"publisher","first-page":"106938","DOI":"10.1016\/j.yebeh.2020.106938","article-title":"Abrupt withdrawal of cannabidiol (CBD): A randomized trial","volume":"104","author":"Taylor","year":"2020","journal-title":"Epilepsy Behav"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00226-9","article-title":"Marijuana, immunity and infection","volume":"83","author":"Klein","year":"1998","journal-title":"J Neuroimmunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.02.012","article-title":"Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists","volume":"10","author":"Greineisen","year":"2010","journal-title":"Int Immunopharmacol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-015-9603-3","article-title":"Effects of cannabinoids on T-cell function and resistance to infection","volume":"10","author":"Eisenstein","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11481-015-9615-z","article-title":"Turning over a new leaf: Cannabinoid and endocannabinoid modulation of immune function","volume":"10","author":"Cabral","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(02)00159-7","article-title":"Effects of delta-9-tetrahydrocannabinol on human immune function and host defense","volume":"121","author":"Roth","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600646R","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"FASEB J"},{"key":"B89","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1038\/s41598-017-15026-z","article-title":"Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation","volume":"7","author":"Zgair","year":"2017","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"crossref","DOI":"10.1016\/S0305-7372(82)80035-2","article-title":"A multi-institutional phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting","volume":"9","author":"Jones","year":"1982","journal-title":"Cancer Treat Rev"},{"key":"B91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0305-7372(82)80034-0","article-title":"Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy","volume":"9","author":"Wada","year":"1982","journal-title":"Cancer Treat Rev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(91)90026-Z","article-title":"Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting","volume":"6","author":"Lane","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27374","article-title":"Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review","volume":"65","author":"Polito","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.305","article-title":"The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. the DATRI 004 study group. division of AIDS treatment research initiative","volume":"13","author":"Timpone","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-015-9599-8","article-title":"Behavioral, metabolic, and immune consequences of chronic alcohol or cannabinoids on HIV\/AIDs: Studies in the non-human primate SIV model","volume":"10","author":"Molina","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-015-9608-y","article-title":"The antitumor activity of plant-derived non-psychoactive cannabinoids","volume":"10","author":"McAllister","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1562","article-title":"Structure and chromosomal localization of the human PD-1 gene (PDCD1)","volume":"23","author":"Shinohara","year":"1994","journal-title":"Genomics."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(87)90122-2","article-title":"Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts","volume":"24","author":"Paterson","year":"1987","journal-title":"Mol Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"108813","DOI":"10.1016\/j.intimp.2022.108813","article-title":"OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer","volume":"108","author":"Lao","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.982082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T16:43:54Z","timestamp":1677516234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.982082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":102,"alternative-id":["10.3389\/fimmu.2022.982082"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.982082","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"982082"}}